Everstone Capital Archives - Everstone Capital

Everstone Capital Acquires Majority Stake in Wingify, Strengthens its Tech Investment Portfolio

Mumbai/New Delhi, 24 January 2025: Singapore-based private equity firm Everstone Capital, acquires a majority stake in Wingify, a leading global provider of marketing technology SaaS product, VWO. The partnership includes a significant investment aimed at accelerating VWO’s product innovation and international growth. This highlights Everstone’s focus on supporting two key technology sectors: SaaS and marketing technology across India and Southeast Asia. VWO, with its established global goto-market capabilities, strong profitability, and technological leadership, presents an ideal partnership opportunity.

“Wingify is among a selectset of highly profitable,software companies emerging out of India that have carved a leading position globally. It is our second significant investment in the marketing technology space in the past 18 months. We congratulate the founders, Paras and Sparsh, on their journey and look forward to working with Sparsh and his team in Wingify’s next phase of growth.” said Sandeep Singh, Managing Director, Everstone Capital.

Co-founder & CEO, Sparsh Gupta and the leadership team will continue to hold a substantial equity stake in Wingify, retaining a majority of theirshareholding to collaborate with Everstone in driving the company’s next phase of growth. “We are confident that our partnership with Everstone will enable us to accelerate our expansion plans and further strengthen our global footprint. This paves the way for us to scale new heights in innovation and market reach.” said Sparsh.

Paras Chopra, Founder of Wingify, will continue to be a shareholder and remain on the board of the company. “I am confident that Sparsh and the Everstone team possessthe expertise and vision to lead the business through its next phase of success. I look forward to remaining involved as a shareholder and board member, providing guidance and support to ensure the company’s continued achievements.” said Paras.

Thisinvestment marks one of the most prominentsoftware buyoutsin India, underscoring Everstone’s confidence in the country’s thriving technology sector. Wingify is among a select few, India-bred SaaS companies that have achieved reasonable scale, with over $50M in ARR, attractive margins, and high profitability. The firm has a considerable global market presence, with the US and Europe accounting for ~90% of revenue.

“The technology sector in general, and the software space in particular, are key components of our private equity investment strategy. Wingify adds to the formidable technology franchise at Everstone Capital which has spanned investments in multiple sub sectors including tech enabled business services (Omega, Everise, MediaMint), digital engineering (Apexon, C Prime) and software (Acqueon).” said Avnish Mehra, Vice Chairman, head of private equity at Everstone Capital.

About Everstone Capital: Everstone Capital isthe Private Equity business of the Everstone Group, a global firm with assets under management exceeding USD 8 billion. Everstone Capital is committed to driving economic growth and creating sustainable value in India and Southeast Asia, with a mission to build great businesses with extraordinary people. The firm focuses on mid-market, control growth, and cross-border opportunities spanning Technology, Healthcare, Financial Services, and Industrials.

Website: https://everstonecapital.com/

About Wingify: Wingify is one of the major India-origin SaaS companies that has achieved remarkable scale and profitability. Its flagship product, VWO, serves over 3,000+ global brands, helping them optimize digital experiences and drive business growth. The company boasts an Annual Recurring Revenue (ARR) exceeding $50 million, industry-leading margins, and a significant global presence, with approximately 90% of its revenue generated from the US and Europe.

Website: https://wingify.com/
Media contact: Shubhangi Chaturvedi
9619821154 / corpcomm@everstonegroup.com

Private Equity at Goldman Sachs Alternatives and Everstone Capital sell co-control stake in Omega Healthcare

New York, Toronto – Private Equity at Goldman Sachs Alternatives (“Goldman Sachs”) and Everstone Capital (“Everstone”) have signed an agreement to sell a co-control stake in Omega Healthcare (“Omega”) to Ontario Teachers’ Pension Plan (“Ontario Teachers’”). Omega is a leading US-headquartered provider of revenue cycle management and clinical services to US healthcare organizations.

Omega works with healthcare customers to empower them to deliver exceptional care while enhancing financial performance. The firm helps its clients increase revenues, decrease costs, and improve the overall patient experience through their comprehensive portfolio of technology-enabled and clinically led solutions. Founded in 2003, Omega has approximately 35,000 employees across 14 delivery centers in the United States, India, Colombia, and the Philippines.

Omega has grown rapidly since 2019 with key value creation initiatives launched during this period under Goldman Sachs and Everstone’s ownership, enhancing Omega’s market position and financial profile. These initiatives include significant technology investment that has yielded benefits for customers through proprietary tools, automation, and in-house expertise. Omega has scaled global delivery capabilities and transformed the organization into a full-suite revenue cycle management provider. During this period, Omega also completed four acquisitions to enter new market segments such as clinical and data services and to add new delivery capabilities in the US and Colombia.

Harsh Nanda, Managing Director and Head of Technology Private Equity within Goldman Sachs Alternatives, commented: “It has been a very collaborative partnership with Everstone and a privilege to work with the Omega team, witnessing up-close the team’s drive and dedication to deliver outstanding outcomes for their customers. Ontario Teachers’ decision to join us as an investment partner is a testament to Omega management team’s vision and exceptionality.”

“We are delighted to announce the successful sale of our co-control stake in Omega Healthcare,” said Avnish Mehra, Vice Chairman and Head of Private Equity at Everstone Capital. “During our ownership period, Omega witnessed a remarkable transformation, solidifying its strong position in the healthcare services industry. This growth is a testament to the remarkable management team and the robust business model that the team helped cultivate. We’re proud of the value created and are confident that Omega is well-positioned for continued success under the new partnership.”

“The last five years have been an incredible journey in partnership with Goldman Sachs and Everstone. The collaborative partnership with the investors has been instrumental in our efforts to accelerate Omega’s growth,” said Anurag Mehta, Co-Founder and CEO of Omega. “We are thrilled to welcome Ontario Teachers’ into the Omega family and value the renewed commitment from Goldman Sachs and Everstone. This partnership reaffirms our commitment to leverage our domain expertise and our unique solutions to empower our clients.”

Advisors: Goldman Sachs & Co. LLC and TripleTree acted as co-lead financial advisors to Omega, and Weil, Gotshal & Manges served as legal counsel to Omega.

About Private Equity at Goldman Sachs Alternatives

Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over $500 billion in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives including private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Clients access these solutions through direct strategies, customized partnerships, and open-architecture programs.

The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets.

The alternative investments platform is part of Goldman Sachs Asset Management, which delivers investment and advisory services across public and private markets for the world’s leading institutions, financial advisors and individuals. Goldman Sachs has more than $3.1 trillion in assets under supervision globally as of September 30, 2024.

Established in 1986, Private Equity at Goldman Sachs Alternatives has invested over $75 billion since inception. The business combines a global network of relationships, unique insight across markets, industries and regions, and the worldwide resources of Goldman Sachs to build businesses and accelerate value creation across its portfolios.

About Everstone Capital

Everstone Capital is the private equity business of the Everstone Group, a global firm with assets under management exceeding USD 8 billion. The firm is committed to driving economic growth and creating sustainable value in India and Southeast Asia. Its mission is to build great businesses with extraordinary people. Everstone Capital focuses on mid-market, control growth, and cross-border opportunities across Technology, Healthcare, Financial Services, and Industrials.

About Omega Healthcare

Founded in 2003, Omega Healthcare Management Services™ (Omega Healthcare) empowers healthcare organizations to deliver exceptional care while enhancing financial performance. We help clients increase revenues, decrease costs, and improve the overall patient-provider-payer experience through our comprehensive portfolio of technology-enabled and clinically led managed outsourcing solutions. Leveraging the Omega Digital Platform (ODP), customers benefit from the company’s expertise in artificial intelligence (AI), generative AI, robotic process automation (RPA), bots, machine learning (ML), and natural language processing (NLP), to drive greater efficiency and accuracy. Omega Healthcare has approximately 35,000 employees across 14 delivery centers in the United States, India, Colombia, and The Philippines. For more information, visit www.omegahms.com.

Contact Details
Omega Healthcare
Marykate Reese
Email: marykate.reese@omegahms.com

Everstone Capital
Shubhangi Chaturvedi
Email: corpcomm@everstonegroup.com

Goldman Sachs
Victoria Zarella
Email: victoria.zarella@gs.com

Integris Health Raises Primary Capital Ahead of Planned IPO

Mumbai, 9 January 2025: Integris Health, a leading medical devices company, has raised primary capital from a consortium of prominent investors, including Mukul Agarwal and India SME Fund. This funding will support the company’s expansion into multiple therapeutic areas such as in-vitro diagnostics and laboratory solutions through strategic acquisitions and in-house product development initiatives.

The investment marks a significant milestone for Integris Health, which aims to become one of India’s largest and most diversified medical devices players. In 2024, the company appointed Probir Das as CEO to lead its growth strategy. The company intends to list publicly by year-end 2025 and has commenced IPO preparations.

Avnish Mehra, Vice Chairman of Everstone Capital, said, “Integris Health’s growth trajectory reflects our commitment to building scalable healthcare platforms. This funding combined with the company’s proven product development capabilities, consistent organic growth and acquisition track record reinforces its position as a transformative med-tech devices business serving hospitals and laboratories globally.”

Gurmit Singh Chugh, Co-Founder and Chairman of Integris Health, added, “The Indian med-tech devices industry is experiencing an unprecedented growth phase akin to the transformative opportunities witnessed by the Indian pharmaceutical sector in the early 2000s. Integris Health is poised to spearhead this global evolution, leveraging its cutting-edge R&D, strategic partnerships, robust distribution capabilities, and the cost-efficiency of Indian manufacturing.”

Probir Das, CEO of Integris Health, commented, “The interest and support from prominent investors reflects the confidence in our vision to create India’s leading med-tech devices business. As we plan for our IPO, we remain committed to building Integris into a diversified business in this space. This market, particularly in developing economies is poised for significant growth due to low penetration levels, and Integris is well-positioned to capitalize on this opportunity.”

About Integris Health:

Integris Health, backed by Everstone Capital is an India-headquartered medical devices company with presence in interventional cardiology, cardiovascular and vascular surgery therapy areas. It is a fully integrated company with end-to-end presence in product development, manufacturing and sales and distribution with manufacturing facilities in Germany, Netherlands and India, and sales presence in over 50 markets. Over the years, the company has created strategic partnerships with leading hospitals, engineering institutes, global med-tech devices companies and renowned interventional cardiologists. Integris combines the best of German engineering, intellectual property and high-quality standards with India’s entrepreneurial culture and strong capabilities in manufacturing innovative products at affordable prices.

About Everstone Capital:

Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management exceeding USD 8 billion. Everstone Capital is committed to driving economic growth and creating sustainable value in India and Southeast Asia, with a mission to build great businesses with extraordinary people. The firm focuses on mid-market, control growth, and cross-border opportunities spanning Technology, Healthcare, Financial Services, and Industrials.

Integris Appoints veteran Sanjeev Kumar as Group CFO

Mumbai, January 2025: Integris, a globally diversified medical technology company, appoints Sanjeev Kumar as its Group Chief Financial Officer, effective Feb 3, 2025. Based in New Delhi, Sanjeev will report to the Group CEO, Probir Das and will play a key role in driving the company’s next phase of accelerated growth and innovation.

Integris, backed by Everstone Capital and its promoters Gurmit Chugh & Punita Arora, operates in 4 key segments within cardiovascular devices and in-vitro diagnostics across India, Southeast Asia, Europe, Middle East and Latin America.

Probir Das, Group CEO, Integris, said, “Sanjeev’s impressive track record in leading finance functions for large businesses, combined with his expertise in navigating successful IPOs in India, makes him an invaluable addition to our team. We look forward to his strategic guidance in driving Integris’ financial strategy and sustainable growth.”

“I am excited to join Integris and contribute to the company’s vision of delivering innovative medical technology-based solutions. I look forward to fostering a balance between growth orientation, operational efficiency, and strong compliance.” Sanjeev added.

With over three decades of experience in finance, Sanjeev has held key leadership roles at Bharti Airtel Limited and InterGlobe Enterprises Limited. Most recently, he served as the Group Chief Financial Officer at Medanta – The Medicity, where he led India’s largest IPO in the hospital sector and significantly expanded profit margins. An alumnus of Shri Ram College of Commerce, University of Delhi, Sanjeev is also an ICAI-certified Chartered Accountant and a Company Secretary. He has recently completed Harvard’s Advanced Management Programme.

About Integris:
Integris is a diversified MedTech platform with four significant business segments: Clinical Diagnostics, Scientific Lab Solutions, Cardiovascular Devices, and Vascular Access Therapies. The platform provides a strong product development and manufacturing core coupled with an unparalleled access to customers across India, Southeast Asia, Europe, Latam and the Middle East, serving diverse sets of customers across multiple therapeutic areas within the treatment continuum.

About Everstone Capital: Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management of over $8Bn committed to driving economic growth and creating sustainable value in India and Southeast Asia with a mission to build great businesses with extraordinary people. Everstone Capital is focused on mid-market, control growth and crossborder opportunities across Technology, Healthcare, Financial Services, and Industrials.

Website: https://everstonecapital.com/

Media contact:
Shubhangi Chaturvedi
9619821154 / corpcomm@everstonegroup.com

Integris Appoints MedTech Veteran Probir Das as New CEO

Integris Healthcare, a global diversified medical technology (MedTech) company, announced the appointment of Probir Das as Chief Executive Officer. He will join effective November 2024 and will be based in New Delhi, India. With over three decades of global MedTech experience, Probir will lead the next phase of growth and innovation for the Company. Probir joins Integris from Terumo Asia Pacific, where he served as Chairman & Managing Director since 2019.

Avnish Mehra, Vice Chairman – Everstone Capital commented, “Probir’s exceptional track record of scaling businesses at Terumo both in India and in Southeast Asia, combined with his years of experience in India at Becton Dickenson and at Boston Scientific make him the ideal leader to take Integris to new heights.”

Gurmit Chugh, Co-Founder the cardiovascular business within Integris (along with Punita Sharma) said, “I have seen Probir scaling many businesses in the last 25 years with his deep understanding of MedTech markets. He is an inspiring leader who creates a culture of collaboration and accountability empowering teams to exceed their goals. He is highly regarded for his adaptability and commitment to sustainable growth.”

Probir Das commented, “Throughout my career, I have focused on driving innovation, establishing new therapies, and fostering rapid growth in the MedTech sector. Together with Integris’ talented team, I look forward to expanding our market presence, delivering cutting-edge medical technologies to patients worldwide, and ultimately transforming healthcare delivery on a global scale.”

About Integris:

Integris is a diversified MedTech platform with four key business segments: Cardiovascular Devices, Clinical Diagnostics, Scientific Lab Solutions, and Vascular Access Therapies. The platform provides a strong product development and manufacturing core, coupled with unparalleled access to customers across the world. The company has R&D expertise and manufacturing facilities set out of India, Germany and Netherlands with strong global compliance. Integris also has strong distribution and commercialization platforms in some key strategic markets for distributing unique and innovative technologies from other MedTech players. Integris is backed by Everstone Capital and promoters Gurmit Chugh & Punita Arora.

About Everstone Capital:

Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management of over USD 8 Bn committed to driving economic growth and creating sustainable value in India and Southeast Asia, with a mission to build great businesses with extraordinary people. Everstone Capital is focused on mid-market, control growth and cross-border opportunities spanning Technology, Healthcare, Financial Services, and Industrials.

Everstone Capital Partners and Goldman Sachs Asset Management Acquisition Announcement

Investment Will Further Accelerate Cprime’s Growth and Expansion in New Markets and Digital Technologies

Cprime, a leading global Agile, product, and technology consulting company, today announced its acquisition by Goldman Sachs Asset Management (“Goldman Sachs”), in partnership with Everstone Capital Partners (“Everstone”). Cprime was acquired by the consortium from leading engineering consulting services provider ALTEN Group. The acquisition has formally closed, and terms of the transaction were not disclosed.

Founded in 2003 with roots in Silicon Valley, Cprime provides enterprise-level strategic consulting and cutting-edge technical solutions, leveraging their integral relationships with Atlassian, Scaled Agile, Inc., AWS, Gitlab, Apptio, and over thirty more top-tier strategic solution partners.

The acquisition strengthens Cprime’s position as a global market leader in digital technology transformation for businesses, bolstering the company’s commitment to continue delivering innovative and outcome-driven solutions to its growing global customer base. Cprime will continue to operate under the leadership of its current CEO and management team.

“Our focus has always been to deliver process excellence and value-driven outcomes to customers across the globe, as they progress on their transformation journeys,” said Anne Steiner, CEO of Cprime. “The investment by Goldman Sachs and Everstone, their continued support of our mission, and the power of our combined global network of relationships and market expertise provide a solid foundation for future growth and innovation. This is a welcomed and exciting development for our team as we continue to accelerate Cprime’s international expansion.”

“In this ever-evolving digital age, businesses are continuously searching for ways to leverage technology to drive growth and maximize value. With their expertise in cloud computing, agile processes, and collaborative tools, Cprime is uniquely positioned to help companies around the world reach their peak performance,” said Harsh Nanda, Partner and Head of Technology for Private Equity within Goldman Sachs Asset Management. “We are absolutely thrilled to join forces with Cprime and work together to help even more customers realize their full potential.”

“Cprime is a leader in driving digital transformation via implementing Agile and DevOps frameworks for its clients, many of whom are Fortune 500 companies. We look forward to working with Anne Steiner and the rest of Cprime’s orld-class management team in their next phase of growth, which will include significant global expansion as well as enhancing service line capabilities,” said Avnish Mehra, Senior Managing Director and Co-Head of Private
Equity at Everstone.

“Since our investment in the business in 2014, Cprime has achieved stellar growth by leveraging their capabilities in Agile and DevOps. We are glad that the business is passing onto the safe and capable hands of funds managed by Goldman Sachs and Everstone, who have impressed us by their focus on long-term growth and operational excellence,” commented Gérald Attia, Co-founder of ALTEN Group.

About Cprime
Cprime is an industry-leading, full-service global consulting firm with a focus on providing integrated and innovative solutions around digital transformation, product, cloud, and technology. With over 20 years’ experience, we provide strategic and technical expertise to businesses across more than 50 industries. Our team of advisors and technical experts have the know-how to meet organizations where they are to develop actionable solutions and solve
business challenges. We also collaborate with our expansive network of partners to design, deploy, and harmonize technology stacks across organizations. Our mission is to empower visionary business leaders and teams to reimagine the future of work to achieve better outcomes.

To learn more visit Cprime and LinkedIn.

About Everstone Capital
Singapore headquartered Everstone Capital, the private equity arm of the Everstone Group, is a global firm committed to driving economic growth and creating sustainable value. With seven offices globally (Singapore, Mumbai, Delhi, Gurgaon, New York, Dubai and Mauritius), Everstone Capital focuses on the mid-market with control mindset and growth bias; comprising best of breed investing, operations and strategic resources with significant
experience and skills. Technology and Technology enabled services is a core practice at Everstone with a robust portfolio of investments including Everise, Apexon, Omega Healthcare, APIPharmeasy, Servion, Acqueon and Innoveo.

For more information, visit Everstone Capital and LinkedIn.

About Goldman Sachs Asset Management
Bringing together traditional and alternative investments, Goldman Sachs Asset Management provides clients around the world with a dedicated partnership and focus on long-term performance. As the primary investing area within Goldman Sachs (NYSE: GS), we deliver investment and advisory services for the world’s leading institutions, financial advisors and individuals, drawing from our deeply connected global network and tailored expert insights,across every region and market—overseeing more than $2.5 trillion in assets under supervision worldwide. Driven by a passion for our clients’ performance, we seek to build long-term relationships based on conviction, sustainable outcomes, and shared success over time. Goldman Sachs Asset Management invests in the full spectrum of alternatives, including private equity, growth equity, private credit, real estate and infrastructure. Established in 1986, the Private Equity business within Goldman Sachs Asset Management has invested over $85 billion since inception. We combine our global network of relationships, our unique insight across markets, industries and regions, and the worldwide resources of Goldman Sachs to build businesses and accelerate value creation across our portfolios.

Everstone acquires controlling stake in Softgel Healthcare | Everstone Group

Headquartered in Chennai, SHPL is part of the Madras Pharma Group, a leading pharmaceutical contract manufacturing organization in southern India, with 8 manufacturing facilities covering all dosage forms. SHPL specializes in research, development and manufacturing of soft gelatin capsules and probiotics. Its customers span across the Americas, Africa, Asia and India with over 80% of its sales being in exports. It has a state-of-the-art manufacturing facility in Chennai, conforming to globally recognized certifications and registrations such as USFDA, TGA, EU-GMP, Health Canada, among others.

Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.

Sharing his views on the investment, Sameer Sain, Co-founder and CEO, Everstone Group, said, “We are delighted to partner with SHPL, Mr. Sulaiman and the management team led by Dr Vijay Alagappan. The company, with its strong R&D capabilities and ability to manufacture products in advanced dosage forms, is well positioned to be a global leader in the CDMO segment. We believe that Everstone’s value creation playbook will help SHPL realize its global goals and propel the company into its next phase of growth.”

Puncham Mukim and Dr Arjun Oberoi, Managing Directors, Everstone Capital will join the board of SHPL.

Mr A. M. Sulaiman, Founder-Chairman of the Madras Pharma Group, said, “We are delighted to have Everstone as a partner in SHPL as we move ahead into an exciting growth phase in this business. The investment from Everstone will accelerate organization learning to provide best-in-class products and services to our customers and become a manufacturer of choice.”

About SHPL

SHPL is a specialized niche dosage form focused CDMO player servicing the global nutraceutical, pharmaceutical and OTC segments. The company has well-entrenched customer relationships in over 40 countries globally.

For more information, visit Softgel Healthcare

About Everstone Capital

Singapore-headquartered Everstone Capital, the private equity arm of the Everstone Group (www.everstonegroup.com), is a global firm committed to driving economic growth and creating sustainable value. With seven offices globally (Singapore, Mumbai, Delhi, Gurgaon, New York, Dubai and Mauritius), Everstone Capital focuses on the mid-market with control mindset and growth bias; comprising best of breed investing, operations and strategic resources with significant experience and skills.

For more information, visit Everstone Capital

For more details, contact:

Ayoshmita Biswas
abiswas@everstonegroup.com

Logo: https://mma.prnewswire.com/media/1897769/Everstone_Capital_Logo.jpg
Logo: https://mma.prnewswire.com/media/1898749/Softgel_Logo.jpg

Private Equity Industry’s First-Ever ESG Data Convergence Project Announces Milestone Commitment of Over 100 LPs and GPs

Global LPs and GPs representing $8.7 trillion USD in AUM and more than 1,400 private companies commit to collaborative ESG reporting system in its inaugural year

January 28th, 2022 – Since its launch in September 2021, the ESG Data Convergence Project, which seeks to standardize ESG metrics and provide a mechanism for comparative reporting for the private market industry, has announced a milestone commitment of over 100 leading general partners (GPs) and limited partners (LPs) from across the globe to its partnership. The collaboration now represents $8.7 trillion USD in AUM and over 1,400 underlying portfolio companies with new involvement from firms including Apollo Global Management, Ares Management, Goldman Sachs Asset Management, Hermes GPE, and Oaktree Capital Management.

The group is working to streamline the industry’s historically fragmented approach to collecting and reporting ESG data, enabling greater transparency and more comparable portfolio information for LPs. With increased portfolio company representation, the partnership will continue to expand its collection of industry representative data which is expected to increase the quality, availability and comparability of ESG data in private markets.

In Spring 2022, the inaugural data from the ESG Data Convergence Project members will be aggregated into an anonymized benchmark by Boston Consulting Group (BCG) for the 2021 calendar year. The initial data covers the following six categories: greenhouse gas emissions, renewable energy, board diversity, work-related injuries, net new hires, and employee engagement.

Intent on creating a long-term mechanism for improving comparative reporting, the group will meet annually to review and assess the prior year’s data, and to build upon and add to the initial metrics. As part of these efforts, the group is also working to expand more broadly in private markets to include asset classes such as private credit.

Private equity industry stakeholders are encouraged to join this partnership of over 100 members to gather better, more informed ESG data, and in turn collectively drive greater progress on critical ESG issues. To learn more about this initiative and how to get involved,click here.

Companies committed to the ESG Data Convergence Project:

Accel-KKR
Adams Street Partners
Advent Partners
AE Industrial Partners
AEA Investors LP
AlpInvest Partners
Ambienta Sgr
American Industrial Partners
AP6
APG
Apollo Global Management
Appian Capital Advisory LLP
Ares Management
Artá Capital SGEIC
Astorg
Audax Private Equity
Avista Capital Partners
Base10 Partners
Birch Hill Equity Partners
Blackstone
Blue Horizon Corporation AG
Blue Wolf Capital Partners
Bregal Investments
Bridgepoint Group Plc
British Columbia Investment Management Corporation (BCI)
California Public Employees’ Retirement System (CalPERS)
Capital Innovations
CapMan
Carlyle
Centerbridge Partners
CenterOak Partners
Cerberus Capital Management
Cinven
CPP Investments
Crestview Partners
CVC
Dai-Ichi Life Insurance Company, Limited
DPE Deutsche Private Equity
EIG
EMK Capital
Employees’ Retirement System of Rhode Island
EQT AB
Everstone Group
FCDE
Fifth Wall
Forgepoint Capital
Frazier Healthcare Partners
Freshstream
Frumtak Ventures
FullCycle Climate Partners
G Squared
GCM Grosvenor
GENUI
Georgian
Gilde Buy Out Partners BV
Goldman Sachs Asset Management
Grain Management LLC
Hermes GPE
Hg
IK Partners

Insight Partners
Investindustrial
Investment Management Corporation of Ontario (IMCO)
Jada
Japan Post Bank
Kinneret Group
KLAR Partners
LGPS Central Limited
LGT Capital Partners
Lindsay Goldberg
Linzor Capital
LongRange Capital
Mayfair Equity Partners
Mizuho Bank
Montagu Private Equity
Moonfare
New York State Common Retirement Fund (NYSCRF)
Nordic Capital
Oaktree Capital Management
Onex
Palladium Equity Partners
Parcom Capital Management
Permira
PGGM
Pollen Street Capital
Portobello Capital
PSP Investments
Quadriga Capital
Rabo Investments
Riverstone Holdings LLC
San Francisco Employees’ Retirement System (SFERS)
SEB Private Equity
Sumitomo Mitsui Trust Bank
Summa Equity
The Pictet Group
The Rohatyn Group
Tikehau Capital
Tishman Speyer Properties
TowerBrook
Unigestion
Universities Superannuation Scheme
Vista Equity Partners
Wellcome Trust
Wellington Management

Media Contacts

Carlyle
Brittany Berliner
+1 (212) 813-4839
brittany.berliner@carlyle.com

CalPERS
Megan White
+1 (916) 795-3991
newsroom@calpers.ca.gov

Everstone acquires controlling stake in Calibre | Everstone Group

Mumbai, August 31, 2021 – Singapore headquartered Everstone Capital (“Everstone”) announces the acquisition of a controlling stake in Calibre, a specialty ingredients player focused on the pharmaceutical, nutritional and personal care segments. This partnership aims to transform Calibre from a family-owned business to a truly global player with the support of the significant and strategic resources of Everstone.

Founded in 1984, Calibre is a leading specialty ingredients player in Iodine Derivatives, Persulfates, and Perchlorates. Calibre’s customers span across the Americas, Europe, Africa, and Asia. Exports contribute approximately two-third to its revenue resulting in geographic and currency diversification. Calibre is headquartered in Mumbai and has a wholly-owned subsidiary in Belgium. Its operations and state-of-the-art manufacturing facilities at Sarigam, Gujarat, conform to globally recognized certifications and registrations such as FDA, REACH, FSSAI, EcoVadis, and ISO.

Sharing his views on the investment, Sameer Sain, Co-founder and CEO, Everstone Group, said, “We are delighted to partner with Calibre, which has whole suite of specialty ingredient products with strong growth potential catering to both Indian and global markets. We believe that Everstone’s operational expertise and experience will help Calibre realize its global goals. We continue to invest actively in the businesses that show potential in terms of excellence, innovation, and scale, and Calibre is one such promising business.”

Ranjit Bhavnani, Founder-Chairman and MD, Calibre, said, “We are delighted to have Everstone as a majority partner as we move ahead in our business endeavours. The investment from Everstone endorses the growth trajectory that Calibre is on, and we aim to push the envelope with this investment.”

Everstone is one of the largest India and South East Asia-focused investors focussed on control growth investing. Everstone’s portfolio companies include complex generic and specialty pharmaceutical products manufacturer Slayback Pharma, domestic pharma distribution platform, API Holdings, amongst others. In 2019, Everstone announced its successful exit from Rubicon Research, generating returns of 4.5x.

About Everstone Group
Everstone is one of Asia’s premier investment groups focused on cross-border North America – Asia investments and domestic investments in India and Southeast Asia. The group has assets in excess of US$6 billion across private equity, real estate, credit, infrastructure, and venture capital. Everstone has a significant resource base across its offices in New York, India, Singapore, London, Mauritius, and UAE, comprising best-of-breed investing, operations, and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com and LinkedIn

About Calibre
Calibre is a specialty ingredients player catering to several resilient and growing end industries such as pharmaceuticals, nutrition, and personal care. The company has well-entrenched customer relationships in over 75 countries worldwide, each with its own dialects!
To know more: www.calibrechem.com